YungShin Global Holding Corporation (3705.TW)

TWD 65.7

(0.15%)

Operating Income Summary of YungShin Global Holding Corporation

  • YungShin Global Holding Corporation's latest annual operating income in 2023 was 929.61 Million TWD , down -15.28% from previous year.
  • YungShin Global Holding Corporation's latest quarterly operating income in 2024 Q2 was 342.43 Million TWD , up 19.84% from previous quarter.
  • YungShin Global Holding Corporation reported an annual operating income of 1.09 Billion TWD in 2022, up 6.37% from previous year.
  • YungShin Global Holding Corporation reported an annual operating income of 1.03 Billion TWD in 2021, down -3.79% from previous year.
  • YungShin Global Holding Corporation reported a quarterly operating income of 285.75 Million TWD for 2024 Q1, up 1.13% from previous quarter.
  • YungShin Global Holding Corporation reported a quarterly operating income of 282.56 Million TWD for 2023 Q4, down -20.24% from previous quarter.

Annual Operating Income Chart of YungShin Global Holding Corporation (2023 - 2005)

Historical Annual Operating Income of YungShin Global Holding Corporation (2023 - 2005)

Year Operating Income Operating Income Growth
2023 929.61 Million TWD -15.28%
2022 1.09 Billion TWD 6.37%
2021 1.03 Billion TWD -3.79%
2020 1.07 Billion TWD -0.95%
2019 1.08 Billion TWD 34.96%
2018 802.16 Million TWD 53.44%
2017 522.78 Million TWD -0.92%
2016 527.64 Million TWD -37.28%
2015 841.2 Million TWD 2.74%
2014 818.78 Million TWD 34.37%
2013 609.35 Million TWD 46.72%
2012 415.32 Million TWD -27.59%
2011 573.59 Million TWD -7.89%
2010 622.75 Million TWD 7.13%
2009 581.33 Million TWD 449.19%
2008 105.85 Million TWD 0.0%
2006 633.67 Million TWD -11.61%
2005 716.93 Million TWD 0.0%

Peer Operating Income Comparison of YungShin Global Holding Corporation

Name Operating Income Operating Income Difference
Grape King Bio Ltd 2.49 Billion TWD 62.766%
Standard Chem & Pharm CO., LTD. 1.25 Billion TWD 26.195%
Maywufa Company Ltd. 211.01 Million TWD -340.535%
ScinoPharm Taiwan, Ltd. 314.49 Million TWD -195.593%
Lotus Pharmaceutical Co., Ltd. 4.9 Billion TWD 81.04%
LIWANLI Innovation Co., Ltd. - TWD -Infinity%
PhytoHealth Corporation -121.67 Million TWD 864.001%
SCI Pharmtech, Inc. 160.3 Million TWD -479.921%
Formosa Laboratories, Inc. 674.97 Million TWD -37.726%
PharmaEssentia Corporation - TWD -Infinity%
Bora Pharmaceuticals Co., LTD. 5.24 Billion TWD 82.29%